Acute pulmonary embolism management starts with severity-based classification, but prompt anticoagulation remains the key first move. Low-risk symptomatic PE may suit early discharge with a safe plan, whereas shock, RV strain, biomarkers or oxygen requirement should push escalation.

Albumin in septic shock still lacks definitive patient benefit. The bedside rule is to keep crystalloids as default and avoid treating a low serum albumin number itself: subgroup signals, early stopping and control-arm crossover can all make neutral trials look more persuasive than they are.